drugset / Trial / NCT03317301
Evaluate the Efficacy and Safety of HL151 Versus Talion Tab. in Pruritus Cutaneus
RandomizedParallel-groupTriple-blindTreatment
Summary
a Multicenter, Randomized, Double-blinded, Active-controlled, Parallel, Phase Ⅲ Study to Evaluate the Efficacy and Safety of HL151 versus Talion Tab. in Pruritus cutaneus. \- Endpoint: VAS Score Change, Investigator's assessment of overall treatment
Timeline
- Start
- 2017-05-17
- Primary completion
- 2017-11-13
- Completion
- 2018-01-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HL151 | Unknown | — | — |
| Comparator | Talion Tab | Unknown | — | — |
Indications
No indication recorded.